Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06422169

Interventistic Clinical Investigation on the Use of Medical Device in Subjects With Mild-moderate Osteoarticular Pain

Interventistic Monocentric Pre-market Clinical Investigation on the Use of Medical Device "ArToFILL" in Subjects With Mild-moderate Osteoarticular Pain

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
PromoPharma spa · Industry
Sex
All
Age
18 Years – 84 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the performance and safety of ArToFILL in subjects with mild to moderate osteoarticular pain

Detailed description

Monocenter, prospective, open label, interventional clinical investigation evaluating the performance and safety of 3 intra-articular injections of ArToFILL for the treatment of mild-moderate osteoarticular pain.

Conditions

Interventions

TypeNameDescription
DEVICEArToFILLArToFILL is an injectable medical device (class III) intended for use as a temporary filler in joints. It is a sterile, non-pyrogenic, colorless and transparent hyaluronic acid gel of non-animal origin. ArToFILL is a hydrogel consisting of a mixture of two different molecular weights of hyaluronic acid, for a total HA concentration of 2.7 %.

Timeline

Start date
2024-05-08
Primary completion
2025-03-08
Completion
2025-05-08
First posted
2024-05-20
Last updated
2024-05-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06422169. Inclusion in this directory is not an endorsement.